News
TheWell Bioscience 2024 Innovations for Advancing 3D Cell Culture
2024 Innovations for Advancing 3D Cell Culture
This year has marked remarkable growth and innovation for TheWell Bioscience. We introduced groundbreaking products, including the VitroGel® Invasion Assay Kits, VitroGel® Starter Kits, VitroPrime Cell Culture Inserts, and VitroPrime Spread-Attach Plate. These innovations further enhance our comprehensive workflow for full lab automation, empowering researchers to achieve greater efficiency and precision in their work. These accomplishments solidify our position as a leader in transforming cell culture assays toward advanced biomedicine.
Product Highlights:
The VitroGel®-Based Invasion Assay Kits are powered by VitroGel® hydrogels (versatile, xeno-free, bio-functional hydrogels that closely mimic the physiological extracellular matrix) coupled with our premium quality VitroPrime™ Cell Culture Inserts, allowing more accurate and consistent invasion and migration studies than animal-based ECM.
VitroGel® Starter Kits
A complete kit with the xeno-free VitroGel® hydrogel and complimentary products for a complete workflow of 3D cell model establishment to downstream analysis with lab automation capability.
VitroPrime™ Spread-Attach Plates
Unique surface treated for superior hydrogel spreading, adherence,
and uniform surface to eliminate the edge effect, solve the floating issue and uneven cell attachment to help promote rapid cell growth and improve cell yields.
VitroPrime™ Cell Culture Inserts
VitroPrime™ Cell Culture Inserts closely mimic the in vivo environment, promoting enhanced attachment, growth, and differentiation of a wide range of cell types.
Explore our xeno-free, easy-to-use, and biofunctional VitroGel® hydrogel system and all its advantages over animal-based ECMs.
Comparison: VitroGel® Hydrogels vs. Animal-based ECMs
VitroGel® offers a defined synthetic hydrogel system that closely mimics the natural ECM environment without animal or human components. This system gives researchers control over mechanical strength, functional ligands, and degradability, allowing for the creation of precise biomimetic environments tailored for various applications in drug discovery, tissue engineering, and cell therapy.
In contrast, animal-based ECMs suffer from batch-to-batch inconsistency and contain over 2,000 undefined components, highlighting the superior consistency and defined nature of the VitroGel® system for advanced biomedical research and development.
Learn The Difference Between VitroGel® vs. Animal-Based ECM >
